Articles tagged "Liver transplantation"

2018 American Transplant Congress
Single Center Experience of HLA-Related Donor Specific Antibody in Living Donor Liver Transplantation
H. Egawa,¹ Y. Kotera,¹ A. Ohmori,¹ S. Yamashita,¹ T. Kato,¹ S. Nemoto,¹ T. Ishizuka,² M. Yamamoto.¹
¹Surgery, Tokyo Women's Medical University, Tokyo, Japan; ²Clinical Laboratory, Tokyo Women's Medical University, Tokyo, Japan.
Although impact of donor specific antibody in liver transplantation has been recognized, significance of desensitization is not established yet. Our aim is to share our…
2018 American Transplant Congress
Hospitalization and Life Support before Liver Transplantation – Easily Available Predictors for Post-Transplant Patient Survival
L. Wiering, P. Ritschl, M. Hippler-Benscheidt, F. Aigner, M. Biebl, D. Eurich, M. Schmelzle, I. Sauer, K. Kotsch, J. Pratschke, R. Öllinger.
Chirurgische Klinik Campus Charité Mitte / Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.
IntroductionCurrently liver allocation -in contrast to allocation of other organs- is based on urgency in many countries and survival benefit is not included. Aim of…
2018 American Transplant Congress
Identifying Differences in Antimicrobial Resistance with a Liver Transplant Antibiogram
J. Rago, M. Crotty, E. Milas, E. Dominguez.
Methodist Dallas Medical Center, Dallas.
Regulatory requirements for antimicrobial stewardship pose a unique challenge in special populations including transplant recipients. Infection following liver transplant can adversely impact patient outcomes. Moreover,…
2018 American Transplant Congress
High Dose Tissue Plasminogen Activator Flush during Donation-after-Cardiac-Death (DCD) Liver Procurements Offers Optimal Outcomes
J. Torabi,² J. Graham,^1,2 S. Bellmare,^1,2 M. Kinkhabwala,^1,2 J. Rocca.^1,2
¹Montefiore Center for Transplantation, Montefiore Medical Center, Bronx, NY; ²Albert Einstein College of Medicine, Bronx, NY.
BackgroundEfforts to expand the donor pool have resulted in increased utilization of donation-after-cardiac-death (DCD) liver donors. Here we report on our experience using high dose…
2018 American Transplant Congress
Assesment of a Novel Chronic Kidney Disease Educational and Goal Setting Tool among Liver Transplant Recipients
R. Leek,¹ J. Park,¹ C. Koerschner,² J. Mawby,³ J. Wright Nunes,⁴ C. Sonnenday,³ P. Sharma.²
¹College of Pharmacy, University of Michigan, Ann Arbor; ²Gastroenterology and Hepatology, University of Michigan, Ann Arbor; ³Transplantation Surgery, University of Michigan, Ann Arbor; ⁴Nephrology, University of Michigan, Ann Arbor.
Background: Stage 4-5 chronic kidney disease(CKD) among liver transplant(LT) recipients is common and associated with diminished patient and graft outcomes. Our previous study showed that…
2018 American Transplant Congress
Renal and Bone Safety in Post Liver Transplant Patients with Chronic Kidney Disease Receiving Tenofovir Alafenamide for HBV Prophylaxis
E. Gane,¹ B. George,¹ S. Munn,¹ H. Wang,² V. Suri,² A. Gaggar.²
¹Auckland City Hospital, Auckland, New Zealand; ²Gilead Sciences, Foster City, CA.
Background and Aims: Chronic Hepatitis B (CHB) remains a leading indication for orthotopic liver transplantation (OLT) globally. Common complications following OLT include renal dysfunction secondary…
2017 American Transplant Congress
Efficacy and Safety of Everolimus with Reduced Tacrolimus or Cyclosporine in Pediatric Liver Transplant Recipients: 12-Month Results from H2305 Study.
A. Weymann,¹ R. Ganschow,¹ B. Ericzon,¹ A. Dhawan,¹ K. Sharif,¹ E.-D. Martzloff,² B. Rauer,² J. Ng,² P. Lopez.²
¹H2305 Study Group, St Louis; ²Novartis Pharma AG, Basel, Switzerland
Purpose: Everolimus (EVR) facilitated calcineurin inhibitor (CNI) reduction has shown improved renal function (RF) without compromising efficacy in adult liver transplant recipients (LTxR). Here we…
2017 American Transplant Congress
Contemporary Outcomes and Risk Factors of Acute Graft-versus-Host Disease After Liver Transplant.
J. Markus, A. Bukannan, B. Kashat, R. Salgia.
Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI
Introduction:Acute graft-versus-host-disease (GVHD) is a rare complication of orthotopic liver transplant (LT) that has an estimated incidence of 0.1%-2% per year. This complication of OLT…
2017 American Transplant Congress
Live Donor Liver Transplantation Using Grafts with More Than Two Bile Ducts – Does It Affect Patient Outcome?
D. Kollmann, G. Sapisochin, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, A. Ganekar, D. Grant, M. Selzner, N. Goldaracena.
Multi Organ Transplant Program, Department of Surgery, Toronto General Hospital, Toronto, ON, Canada
Introduction: It's been described that the use of live donor (LD) liver grafts with multiple bile ducts (BD) increases the risk of BD related complications…
2017 American Transplant Congress
B Cells in Liver Transplant Tolerance.
M. Morita,¹ G. Asonye,¹ N. Gupta,¹ J. Fung,² C. Miller,³ S. Qian,^1,3 L. Lu.^1,3
¹Immunology, Cleveland Clinic, Cleveland; ²University of Chicago, Chicago, MI; ³General Surgery, Cleveland Clinic, Cleveland, OH
In mice liver transplantation, the liver allografts can be accepted across fully mismatched MHC without immunosuppression. After transplantation, T cells infiltrate into the graft in…